HIMS rebounds on GLP-1 growth and rising earnings estimates, while DXC slumps amid falling sales and eroding investor ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

We came across a bearish thesis on Hims & Hers on FJ Research’s Substack. As of 3ʳᵈ July, Hims & Hers’s share was trading at ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS ) between April 29, 2025 and June 23, 2025, both dates inclusive (the ...

Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...

On this news, Hims & Hers' stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

The Odisha Government today issued strict instructions to all public and private universities, as well as government and unaided degree colleges under the Higher Education Department, to constitute ...

Bhubaneswar: In view of the self-immolation attempt by a 20-year-old student over alleged sexual harassment at a college in Balasore district on Satur.

Bhubaneswar: In the wake of the self-immolation attempt by a female student of Fakir Mohan Autonomous College in Balasore, ...

President Donald Trump will announce $70 billion in artificial intelligence and energy investments in Pennsylvania on Tuesday, as part of White House efforts to accelerate development of emerging ...

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...